Vaccine hesitancy among ethnic minority Britons
Concerns about new coronavirus variants and a possible exit wave are a reminder that there is still work to be done to defeat the pandemic. We consider how the uneven impact of the pandemic across different ethnic groups is mirrored by the uneven way they are emerging from it, and look at how important vaccine uptake is to preventing racial disparities from widening further.
The Humdrum of Life Under Lockdown
Having spent more than a year in and out of lockdowns, many of us have started to experience unexplainable symptoms such as tiredness and a general lack of motivation as we muddle through the days. This cognitive fog is a result of pandemic burnout as we go through the same motions every day.
Switching to an alternative survey method to assess crime levels in Scotland during the COVID-19 pandemic
Emily Gray and Chris Martin of Ipsos MORI Scotland explain the alternative methodological approach we took so that evidence to inform crime and justice decision-making in Scotland could still be collected during the pandemic.
What matters to people about the future of the UK landscape? A public dialogue on the future of land-use
Policymakers and land managers will need to consider the public’s views both of long-term risks and the immediate impacts upon their everyday lives, according to a major new public dialogue project by Ipsos MORI for the Royal Society.
Research into the customs intermediaries sector: Wave 2 summary report
This summary report presents the key findings from the Wave 2 survey conducted by Ipsos MORI into the customs intermediaries sector, as well as the sizing exercise undertaken in partnership with Perspective Economics, on behalf of Her Majesty’s Revenue and Customs (HMRC).
What are the views and concerns of the public regarding genome editing technology uses and applications?
These are reports from a series of public dialogues undertaken by Ipsos MORI for the ORION consortium. The dialogues focused on the views and concerns of the public regarding the current uses and implications of genome editing technology in research institutions in the ORION consortium.